Comparison of the Efficacy of Oral Irrigator Versus Interdental Brushes in the Oral Hygiene of Patients With Gingivitis: a Randomised Study
Launched by UNIVERSITÉ DE REIMS CHAMPAGNE-ARDENNE · May 26, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of two different tools for improving oral hygiene in patients with gingivitis, a common gum disease that can lead to more serious dental issues if not treated. The trial will compare the use of an oral irrigator, which uses a combination of water and air to clean between teeth, against interdental brushes, which are small brushes designed to clean between teeth. Researchers want to find out which method is better at reducing inflammation and improving gum health.
To participate in this study, individuals need to be adults aged 65 to 74 who have gingivitis, meaning their gums bleed when they brush. They should be able to clean their teeth on their own and understand instructions in French. Certain people, like those currently using these cleaning tools, those with specific medical conditions, or pregnant women, will not be eligible to join. Participants can expect to learn more about managing their gum health while contributing to important research that could improve oral care practices for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • with gingivitis (according to the International Classification of Periodontal Diseases; Chapple et al., 2018 i.e. a BOP greater than 10%).
- • with at least 10 pairs of antagonistic teeth
- • able to carry out oral hygiene procedures independently
- • able to understand the instructions for using interdental devices
- • fluent in French
- • adults
- • affiliated to a social security scheme
- • agreeing to take part in the study
- Exclusion Criteria:
- • daily use of one of the study devices (hydropulper, whatever the model, or calibrated interdental brushes)
- • with a medical history that could compromise the protocol (psychiatric, medical or pharmacological disorders such as the use in the week prior to inclusion of anti-inflammatory drugs, antibiotics or any compound that could alter or modify the inflammatory response)
- • with eating disorders
- • with ongoing orthodontic treatment
- • protected by law (guardianship, curatorship, safeguard of justice)
- • pregnant or breast-feeding women
- • refusing to take part in the study
About Université De Reims Champagne Ardenne
Université de Reims Champagne-Ardenne (URCA) is a distinguished higher education institution located in France, recognized for its commitment to advancing research and innovation in various fields, including health sciences. With a strong focus on interdisciplinary collaboration, URCA actively engages in clinical trials aimed at improving patient outcomes and contributing to medical knowledge. The university fosters a dynamic research environment, equipped with state-of-the-art facilities and a network of experienced professionals, ensuring the integrity and rigor of its clinical studies while prioritizing ethical standards and participant safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported